FDA grants full approval to Bayer's Vitrakvi for NTRK fusion-positive solid tumors in adults and children. Clinical trials show a 60% overall response rate and median response duration of 43.3 months ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Regeneron Pharmaceuticals ...
Jarell Quansah has completed his move from Liverpool to Bayer Leverkusen on a five-year deal through to 2030. Liverpool say the deal is worth £30million and will include a buy-back option for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback